CAVAN JOHN T (CFO) purchased 1500.0% of their position (4.50K shares) of HEPION PHARMACEUTICALS, INC. on the open market
Open‑market purchase worth $7.3K — a major conviction buy. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 11/30/2020ACC: 0001104659-20-130531
Officer· CFO
Since Jul 2018
+4.50K
Net shares
Net buyer
$7.3K
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
4.50K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+4.50K
Price / share
$1.62
Trade value
$7.29K
% of position
1500.0%
11/25/2020
300.00→4.80K
Total
Net shares
+4.50K
Net value
$7.29K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 11/25/2020 | P · Purchase | +4.50K | $1.62 | $7.29K | 1500.0% | 300.00 | 4.80K |
| Total | +4.50K | $7.29K | ||||||
Derivative Transactions0
No derivative transactions reported